{"id":"NCT01442376","sponsor":"Helsinn Healthcare SA","briefTitle":"Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Different Doses of Palonosetron Compared to Ondansetron in the Prevention of CINV in Pediatric Patients Undergoing Single and Repeated Cycles of MEC or HEC","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2012-10","completion":"2012-11","firstPosted":"2011-09-28","resultsPosted":"2014-07-28","lastUpdate":"2014-08-07"},"enrollment":502,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Chemotherapy-Induced Nausea and Vomiting"],"interventions":[{"type":"DRUG","name":"Palonosetron","otherNames":[]},{"type":"DRUG","name":"Palonosetron","otherNames":[]},{"type":"DRUG","name":"Ondansetron","otherNames":[]},{"type":"DRUG","name":"Placebo to Ondansetron","otherNames":[]},{"type":"DRUG","name":"Placebo to Ondansetron","otherNames":[]},{"type":"DRUG","name":"Placebo to Palonosetron","otherNames":[]}],"arms":[{"label":"Palonosetron 10 mcg/kg","type":"EXPERIMENTAL"},{"label":"Palonosetron 20 mcg/kg","type":"EXPERIMENTAL"},{"label":"Ondansetron","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective is to evaluate the efficacy of two different doses of IV palonosetron in the prevention of chemotherapy induced nausea and vomiting in MEC and HEC patients through 120 hours after start of chemotherapy in single and repeated chemotherapy cycles. The secondary objectives are to evaluate the safety and tolerability of IV palonosetron in pediatric patients and evaluate the pharmacokinetics of IV palonosetron in a subset of pediatric CINV patients.","primaryOutcome":{"measure":"Proportion of Patients With Complete Response 0 to 24 Hours (Acute Phase) in Cycle 1","timeFrame":"0 to 24 hours after T0","effectByArm":[{"arm":"Palonosetron 10 mcg/kg","deltaMin":54.2,"sd":null},{"arm":"Palonosetron 20 mcg/kg","deltaMin":59.4,"sd":null},{"arm":"Ondansetron","deltaMin":58.6,"sd":null}],"pValues":[{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":21},"locations":{"siteCount":67,"countries":["United States","Argentina","Austria","Bulgaria","Chile","Czechia","Estonia","France","Germany","Hungary","Peru","Poland","Romania","Russia","Serbia","Ukraine"]},"refs":{"pmids":["26795844"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":68,"n":167},"commonTop":["Anaemia","Leukopenia","Thrombocytopenia","Neutropenia","Pyrexia"]}}